Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation. - Wikidata - awgldk - TriplyDB

Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation.

Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation.

http://www.wikidata.org/entity/Q33391457

about

A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury Hematopoietic cell transplantation-associated thrombotic microangiopathy: a review of pathophysiology, diagnosis, and treatment Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy?Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus/sirolimus-based graft-versus-host disease prophylaxis Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy.Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus.Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults Hematopoietic stem cell transplant-associated thrombotic microangiopathy: review of pharmacologic treatment options.Outcomes of plasma exchange in patients with transplant-associated thrombotic microangiopathy based on time of presentation since transplant.Abnormal echocardiography 7 days after stem cell transplantation may be an early indicator of thrombotic microangiopathy.Fragmented Red Cell as a Possible Favorable Prognostic Marker of Hematopoietic Stem Cell Transplantation Associated Thrombotic Microangiopathy.Histologic Features of Intestinal Thrombotic Microangiopathy in Pediatric and Young Adult Patients after Hematopoietic Stem Cell Transplantation Idiopathic Pneumonia Syndrome and Thrombotic Microangiopathy Following Nonmyeloablative Haploidentical Peripheral Blood Stem Cell Transplantation and Posttransplant Cyclophosphamide: A Case Report Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy.Eculizumab in Transplant-Associated Thrombotic Microangiopathy.Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation.The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy.Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.Post-bone marrow transplant thrombotic microangiopathy.New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy.Recombinant thrombomodulin for secondary thrombotic thrombocytopenic purpura.Remission of microangiopathy in transplanted thalassemic child.Acute kidney injury in HCT: an update.Is complement blockade an acceptable therapeutic strategy for hematopoietic cell transplant-associated thrombotic microangiopathy?Use of defibrotide to treat transplant-associated thrombotic microangiopathy: a retrospective study of the Paediatric Diseases and Inborn Errors Working Parties of the European Society of Blood and Marrow Transplantation.Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation.Central nervous system complications after allogeneic hematopoietic stem cell transplantation.Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies.Renal and neurological response with eculizumab in a patient with transplant associated thrombotic microangiopathy after allogeneic hematopoietic progenitor cell transplantation Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy.Impact of treatment and outcomes for patients with posttransplant drug-associated thrombotic microangiopathy.Transplantation-associated thrombotic microangiopathy isolated to a congenital anomaly of the lung.Thrombotic microangiopathy with concomitant GI aGVHD after allogeneic hematopoietic stem cell transplantation: Risk factors and outcome.Risk and prognostic factors of transplantation-associated thrombotic microangiopathy in allogeneic haematopoietic stem cell transplantation: a nested case control study.Bone marrow transplant-associated thrombotic microangiopathy without peripheral blood schistocytes: a case report and review of the literature.

P2860

Q26992169-3FBFDC3D-977C-4F68-823E-45070A76D061 Q28069228-65605954-5D88-44F9-B847-72ED8C9D2B9B Q30276550-13D02F07-7177-40B4-8AE6-32D5DAC43E66 Q33402385-48798A68-6B87-4B34-851D-4598D2B1A3A5 Q33403897-A53831CA-73BA-48AF-8552-E42787832F80 Q33408788-9A23D879-6D5B-4BCD-ABCD-2A708671CEB0 Q33412325-B0531B5A-E06A-4D65-9B8D-2342DD943002 Q33413498-13B5B3EA-DE90-4ADA-A0E1-8F2575A2A847 Q33415603-FF5A2732-FE7D-4B5B-B9BB-30361D352C77 Q33417613-8AE0A367-0BDA-4E0C-A708-85611C60DC71 Q33417690-46289A87-9116-4E86-8CDD-09E9109B8F19 Q33418088-468D844F-FFC2-4BC6-A403-BD5DC25B3D81 Q33418635-109713D0-2F32-4FE5-861C-2FE3D8A2BF3D Q33424204-7BEBEECF-2F5D-4447-8889-8FBA94DCC424 Q33424660-11A7A9B2-1AA5-4868-A5EC-EFF12F297266 Q33424902-B2F39FB1-8E0E-421F-870F-C7B79828478D Q33425079-5F54B757-1C2A-4956-8382-78B89F1F6205 Q33426602-D8186833-521B-4407-AB04-FE915C08CA97 Q33427838-CF734924-597F-47BF-9F91-97741F8175FA Q33428744-3D010101-8E1D-4E97-A484-65B55F794AAA Q33430697-B9B3E947-AF15-49BD-BED5-5F7420D3E18C Q33432069-3238963F-6CB4-4C0F-9DF6-2CDAAE425FD1 Q33433122-FBDC2EAB-040E-4003-AC07-59E37730F934 Q34316381-27AC7F02-102E-4D92-B0C4-21B1B544DDBE Q38726036-4C451927-74C1-47DC-AD66-D574EE1C89D4 Q38806679-9A93CD12-8992-47A0-983D-3C4DCA1B5FEE Q39018396-E372B0FB-7292-4719-818E-CB8396158960 Q40096407-63C371B8-3EA5-401C-81B2-3DD9BF9BE1B6 Q41923053-772E05B9-8497-4C23-ACBC-0D93A7518D2B Q41992358-4151680A-BE59-427C-B676-6E626058F54C Q42200268-5E64A587-19FC-426C-AF65-3FDCE5CCE50C Q45932533-D76993AD-3066-4FBA-BEF0-47354A54772E Q47912606-64661C46-AB0C-43A8-B4F2-E63168A1C8B0 Q48199990-1C7F8ECF-77CB-424A-8B68-A12DFCBC9453 Q48346280-E6C5CB1D-D2F3-4434-919E-5FBFCAA9ABF7 Q53091032-EED7FAE8-95E4-4072-8497-440EDB900E80 Q55431201-F893ECF7-8B93-42FE-BECF-76CC23D69913

P2860

Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation.

http://www.wikidata.org/entity/Q33391457

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Validation of recently propose ...... tic stem-cell transplantation.

@ast

Validation of recently propose ...... tic stem-cell transplantation.

@en

type

label

Validation of recently propose ...... tic stem-cell transplantation.

@ast

Validation of recently propose ...... tic stem-cell transplantation.

@en

prefLabel

Validation of recently propose ...... tic stem-cell transplantation.

@ast

Validation of recently propose ...... tic stem-cell transplantation.

@en

P1433

Q33391457-008E0957-E35E-4F30-9166-41C4F2A04FC5

P1476

Q33391457-BE0A73D1-4D7F-4459-A9ED-844B7449BD66

P2093

Q33391457-223974BC-B15A-4B52-B0E3-4336EC689C46

Q33391457-42D1CD1A-AFFE-4DB4-9A02-06F765406E29

Q33391457-6453EDC7-B135-44A4-AA53-67641E1C4E4C

Q33391457-7A2C4F0D-2DEF-4E66-A2E8-AE123070A4DA

Q33391457-871B0634-85CB-45DC-AE3D-08DC410B7E5B

Q33391457-8CE36FF4-EF88-4A19-9F34-6699CBE57669

Q33391457-9A53E477-208B-4317-86B6-BD2361E46D41

Q33391457-C48275F9-4430-4895-A42C-43BE105310CA

Q33391457-CFBD5C77-F81A-4AC5-8C24-7E4220E595D7

Q33391457-E0C16C6D-C90A-46C3-B2BE-CE957D7475AF

P304

Q33391457-A1815D80-F212-47CC-A1FC-8F3552CC60B1

P31

Q33391457-4938C64B-A944-4171-A891-A7E10C77F665

P356

Q33391457-1CF14F70-6346-4140-BB41-A8AA6349458F

P433

Q33391457-76EB695A-2E34-422B-9A1D-907F5F5EEBA8

P478

Q33391457-724B71C8-0838-4BDD-B4D0-6582A5F5912B

P50

Q33391457-9DBD81C3-D5D0-4D9C-93EF-BB296EEB0450

P577

Q33391457-9D2F02B0-D3C0-4AB8-BC9D-22EF4A876750

P698

Q33391457-6BD3EDD6-C630-48F5-9608-C0EA6F8405AD

P356

TP.0B013E3181F24E8D

P1433

Transplantation

P1476

Validation of recently propose ...... tic stem-cell transplantation.

@en

P2093

Byung-Sik Cho

http://www.w3.org/2001/XMLSchema#string

Chang-Ki Min

http://www.w3.org/2001/XMLSchema#string

Chong-Won Park

http://www.w3.org/2001/XMLSchema#string

Dong-Wook Kim

http://www.w3.org/2001/XMLSchema#string

Hee-Je Kim

http://www.w3.org/2001/XMLSchema#string

Jong-Wook Lee

http://www.w3.org/2001/XMLSchema#string

Ki-Seong Eom

http://www.w3.org/2001/XMLSchema#string

Seok Lee

http://www.w3.org/2001/XMLSchema#string

Seung-Ah Yahng

http://www.w3.org/2001/XMLSchema#string

Sung-Eun Lee

http://www.w3.org/2001/XMLSchema#string

P304

918-926

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/TP.0B013E3181F24E8D

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20717073

http://www.w3.org/2001/XMLSchema#string